Navigation Links
Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference
Date:6/18/2008

SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that Frank Karbe, executive vice president and chief financial officer at Exelixis, will present at the Piper Jaffray Europe Conference at 3:40 a.m. PT/6:40 a.m. ET/11:40 a.m. London, UK time on Wednesday, June 25, 2008. Mr. Karbe will discuss updates to the company's development pipeline and corporate strategy.

The presentation will be webcast and may be accessed in the Event Calendar page under Investors on the Exelixis website at http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb, Genentech, Wyeth Pharmaceuticals, and Daiichi-Sankyo. For more information, please visit the company's website at http://www.exelixis.com.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Corporation (Nasdaq: DNDN ) announced today that it ... of its common stock at a price to the ... to the underwriters a 30-day option to purchase up ... cover overallotments, if any. The offering is expected ... closing conditions. ,, J. P. Morgan Securities Inc. and ...
(Date:12/10/2009)... Calif., Dec. 10 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that Dan Lemaitre, ... the Endologix Board of Directors effective December 11, ... and three non-independent directors. ,, Franklin D. Brown, ... to welcome Dan Lemaitre to the Endologix Board ...
(Date:12/10/2009)... 10 With the economy and markets exhibiting ... largest, fastest-growing small cap equity research provider, will seek ... opportunities within the micro cap market at the firm,s ... 11, 2010 at the Grand Hyatt Hotel in New ... overlooked and undervalued by much of Wall Street, but ...
(Date:12/10/2009)... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and ... at various stages of development, today provided an ... in the merger of Cytopia Ltd. into YM, ... 2009. The board of directors of Cytopia has ...
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Endologix Appoints Dan Lemaitre to its Board of Directors 2Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4
... wondered why a,starfish can completely grow a new arm, ... salamander can regenerate a severed leg, but human beings,have ... have asked the same,questions for a long time and, ... find the answers. What,s even,more exciting is that much ...
... 8 Pharmaceutical Institute, a,subsidiary of Campbell Alliance, ... and biotech industry, today announced,the release of a ... dynamic market environment and offering key new insights ... new edition of "Understanding Pharma" analyzes nine key ...
... 8 RADI Medical Systems today,announced improvements ... PressureWire(R) Certus, which will begin shipments immediately., ... The latest generation of the PressureWire(R) Certus ... provides three key,advantages for physicians. The new ...
Other Biology Technology:Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp 2Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp 3Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 2Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 3Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 4Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry 5RADI Medical Systems Launches Next Generation PressureWire(R) Certus 2
(Date:12/13/2009)... have resolved a question about how a popular ... using biosensors that reveal previously hidden components of ... delusions and hallucinations characterize the illness, people with ... information in a particular order, difficulties that interfere ... function well, said Lee Schroeder, a student in ...
(Date:12/11/2009)... the global "green" trend, educators worldwide are ... enhance students, science knowledge. Studies have revealed ... raises not just science scoresenvironmental-based lessons can ... subject areas. Naturally, educators are interested in ... lessons into the classroom in hopes of ...
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
Breaking Biology News(10 mins):New biosensors reveal workings of anti-psychotic drugs in the living brain 2Students learn environmental stewardship, improve science scores 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Women More Prone to Die in Month After Heart Attack 55329 1Women More Prone to Die in Month After Heart Attack 55329 2Women More Prone to Die in Month After Heart Attack 55329 3More Women Surviving After Early Breast Cancer 55327 1More Women Surviving After Early Breast Cancer 55327 2More Women Surviving After Early Breast Cancer 55327 3Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 1Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 2Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 3
... & Children,s Hospital and the University of Adelaide, Australia, ... with high blood pressure during pregnancy and pre-term birth. ... of Obstetrics & Gynaecology, are a major step forward ... blood pressure in pregnancy. , The research has been ...
... balance of nature looms prominently in the public mind these ... declining fish stocks are but a few of the issues ... is it? , It depends on whom you ask, ... the School of Life Sciences specializing in biology and society. ...
... devastates Manhattan, but no group takes credit. The pressure ... on sketchy information, the president orders an attack, but ... the wrong country. Things go downhill from there. , ... of 12 scientists with extensive nuclear expertise, headed by ...
Other Biology News:Herpes virus link to complications in pregnancy 2Managing uncertainty important in ecological balance: ASU researcher 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 3
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Phospho-FADD (Ser194) Antibody (Human Specific)...
Biology Products: